Decreased soluble cell adhesion molecules after tirofiban infusion in patients with unstable angina pectoris

Thrombosis Journal

Table 1 Characteristics of the study groups

	Group IA (n = 15)	Group IB (n = 20)	Group II (n = 10)	Group III (n = 10)
Mean age (yr)	57.7 ± 10.2	57.8 ± 8.7	53.3 ± 7.4	56.8 ± 11.8
Male sex (%)	86	90	40	40
DM (%)	13	25	0	0
Current smoker (%)	80	45	60	70
HT (%)	60	35	70	30
BMI	33.7 ± 6.8	28.9 ± 4.5	26.1 ± 2.5	26.3 ± 3.1
WBC (/mm ³ )	9044 ± 2097	8685 ± 2541	6200 ± 964	6530 ± 1240
ESR (mm/hr)	28.3 ± 16.2	22.4 ± 14	6.7 ± 1.9	8.5 ± 1.8
TC (mg/dl)	209.9 ± 69.1	181.2 ± 31.6	199.2 ± 46.5	200 ± 38.2
TG (mg/dl)	202 ± 120	156.8 ± 86.4	101.9 ± 32	113.6 ± 41.7
HDL-C (mg/dl)	40.5 ± 13	41.4 ± 9.9	32.8 ± 4.2	41.1 ± 9.8
LDL-C (mg/dl)	119 ± 47	109 ± 26.6	102.7 ± 24	107 ± 37.5
Extent of CAD
1 vessel (%)	0	20	70	0
2 vessel (%)	54	20	30	0
3 vessel (%)	46	60	0	0

Group IA: Patients with unstable angina pectoris and tirofiban infusion, Group IB: Patients with unstable angina pectoris but no tirofiban infusion, Group II: Patients with stable angina pectoris, Group III: patients with normal coronary angiography, DM: Diabetes mellitus, HT: Hypertension, BMI: Body mass index, WBC: White blood cell, ESR: Erythrocyte sedimentation rate, TC: Total cholesterol, TG: Triglyceride, HDL-C: High density lipoprotein cholesterol, LDL-C: Low density lipoprotein cholesterol, CAD: Coronary artery disease.

ISSN: 1477-9560